Abstract: span style="color: rgb(51, 51, 51); font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 12.800000190734863px; line-height: 19px;">A research group is working to advance the development of technology merging radiation therapy and magnetic resonance imaging (MRI) technology in a single system.
April 22, 2013 - The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) today signed an agreement with Elekta and Royal Philips Electronics to join a research group to advance the development of technology merging radiation therapy and magnetic resonance imaging (MRI) technology in a single system.
NKI-AVL is the third member of the research consortium, which will comprise leading radiation oncology centers and clinicians, and already includes the University Medical Center Utrecht and The University of Texas MD Anderson Cancer Center. The researchers expect a MRI-guided radiation therapy system will provide physicians with exceptional images of a patient’s soft tissues and tumor during radiation therapy.
- MRI-guided radiation therapy is expected to provide physicians with exceptional images of a patient’s soft tissues and tumor during radiation therapy.
This advancement will permit clinicians to adapt treatment delivery in real time for the most precise cancer treatments possible.
“MRI-guided radiotherapy allows optimal imaging and will therefore improve the accuracy of our treatment delivery. Building on our experience with cone beam CT-guidance, we are highly motivated to collaborate within the research consortium and contribute to the implementation of MRI-guided adaptive radiotherapy,” said Professor Marcel Verheij, Head of the Radiotherapy Division at NKI-AVL.
“This research exemplifies the essential role that imaging plays in the development of more targeted treatments for cancer,” said Gene Saragnese CEO Imaging Systems at Philips Healthcare. ”The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital has played a crucial role in the software development for CT-guided radiation therapy a decade ago, and this expertise complements the skills that we already possess in this research consortium.”
For more information: www.elekta.com, www.philips.com, www.nki.nl/Research/, www.mdanderson.org, and www.appliedradiationoncology.com